NCT06180551 Homburg Renal Evaluation Study on the Clinical Utility of Early AKI Diagnosis
| NCT ID | NCT06180551 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Universität des Saarlandes |
| Condition | Acute Kidney Injury |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,000 participants |
| Start Date | 2023-12-01 |
| Primary Completion | 2026-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,000 participants in total. It began in 2023-12-01 with a primary completion date of 2026-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Critically ill patients are at risk of developing a sudden decrease of kidney function which may be detected by a decrease in urine output or is diagnosed on the basis of blood tests for substances normally eliminated by the kidney, primarily creatinine. Because it takes about 24 hours for the creatinine level to rise, even if both kidneys have ceased to function, better markers are needed. This trial is investigating if the marker urinary dickkopf-3 (uDKK3) allows an early prediction of a sudden decrease of kidney function.
Eligibility Criteria
Inclusion Criteria: * Patients treated on the intensive care units of Saarland University Hospital. Exclusion Criteria: * Patients on renal replacement treatment before admission to the intensive care unit. * Patients with chronic kidney disease stage CKD G3b or below. * Known kidney disease. * Kidney transplantation. * Intoxications leading to dialysis treatment. * Participation in other clinical trials.
Contact & Investigator
Stefan Neuhaus, MD
PRINCIPAL INVESTIGATOR
Universität des Saarlandes
Frequently Asked Questions
Who can join the NCT06180551 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Acute Kidney Injury. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06180551 currently recruiting?
Yes, NCT06180551 is actively recruiting participants. Contact the research team at stefan.neuhaus@uks.eu for enrollment information.
Where is the NCT06180551 trial being conducted?
This trial is being conducted at Homburg, Germany.
Who is sponsoring the NCT06180551 clinical trial?
NCT06180551 is sponsored by Universität des Saarlandes. The principal investigator is Stefan Neuhaus, MD at Universität des Saarlandes. The trial plans to enroll 1,000 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.